Life Scientist > Biotechnology

Single daily pill for Parkinson's disease developed

06 October, 2020

Scientists have developed a pill which uses the stomach as a drug reservoir and delivers medicines slowly over time to patients with Parkinson's disease.

Diabetes drug benefits cognition, pregnancy outcomes

29 September, 2020

Metformin could be particularly beneficial for people with type 2 diabetes who are older or looking to become pregnant, as discovered by two separate studies.

TGA approves gene therapy to treat retinal disease

25 September, 2020

The TGA has registered Novartis's LUXTURNA, the first gene therapy in Australia, for the treatment of patients with inherited retinal dystrophy.

Aus Govt joins COVAX, funds more local COVID-19 vaccines

23 September, 2020

The Australian Government has joined the COVAX facility, enabling the purchase of COVID-19 vaccine doses as they become available.

Combining precision medicines can treat drug-resistant cancers

22 September, 2020

Launching a dual-pronged attack on tumours using a combination of two precision medicines could treat patients with multiple common cancers.

Cytiva Xcellerex Automated Perfusion System (APS)

21 September, 2020

The system's automation capabilities include automated filter switching, liquid management and cell bleed, reducing risk for human error and increasing process robustness.

Cortical vision device could restore sight to the blind

18 September, 2020

The bionic vision system makes it possible to treat many conditions that currently have treatment limitations, thanks to the use of electronic implants that sit on the surface of the brain.

Steroids improve outcomes for severe COVID-19 infections

16 September, 2020

Studies of critically ill patients with COVID-19 show that fewer patients died and less ICU support was required when patients received corticosteroids.

Drug improves bone growth in children with dwarfism

11 September, 2020

A phase 3 clinical trial has shown that a new drug boosts bone growth in children born with achondroplasia — the most common type of dwarfism.

CSL agrees to manufacture COVID-19 vaccines for Australia

09 September, 2020

Biotech company CSL has signed two separate heads of agreement (HoA) for COVID-19 vaccines should clinical trials prove successful.

Honeybee venom kills aggressive breast cancer cells

03 September, 2020 by Lauren Davis

Venom from honeybees has been found to induce cancer cell death in hard-to-treat triple-negative breast cancer, with minimal effect on healthy cells.

Precision NanoSystems NanoAssemblr Ignite for developing mRNA treatments and vaccines

01 September, 2020

The NanoAssemblr platform from Precision Nanosystems enables the rapid, reproducible and scalable manufacture of next-generation nanoparticle formulations such as lipid nanoparticles and liposomes to encapsulate a payload such as a SAM.

61medical brings Aussie medtech manufacturing onshore

28 August, 2020

The company has been launched in Queensland to help accelerate the development and commercialisation of Australian-born medical devices for the global market.

In a pinch: drug delivery through the skin

27 August, 2020

The formation of 'micropores' underneath the skin allows drugs applied on the surface to diffuse through it more easily.

New drug treatment reverses asthma symptoms in animal models

24 August, 2020

The drugs work through a mechanism that is distinct from currently prescribed medicines for asthma and chronic obstructive pulmonary disease.

  • All content Copyright © 2020 Westwick-Farrow Pty Ltd